These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of Vasoactive Intestinal Polypeptide on Development of Migraine Headaches: A Randomized Clinical Trial. Pellesi L; Al-Karagholi MA; De Icco R; Coskun H; Elbahi FA; Lopez-Lopez C; Snellman J; Hannibal J; Amin FM; Ashina M JAMA Netw Open; 2021 Aug; 4(8):e2118543. PubMed ID: 34357396 [TBL] [Abstract][Full Text] [Related]
3. The effect of Lu AG09222 on PACAP38- and VIP-induced vasodilation, heart rate increase, and headache in healthy subjects: an interventional, randomized, double-blind, parallel-group, placebo-controlled study. Rasmussen NB; Deligianni C; Christensen CE; Karlsson WK; Al-Khazali HM; Van de Casteele T; Granhall C; Amin FM; Ashina M J Headache Pain; 2023 May; 24(1):60. PubMed ID: 37231350 [TBL] [Abstract][Full Text] [Related]
4. PACAP38 induces migraine-like attacks in patients with migraine without aura. Schytz HW; Birk S; Wienecke T; Kruuse C; Olesen J; Ashina M Brain; 2009 Jan; 132(Pt 1):16-25. PubMed ID: 19052139 [TBL] [Abstract][Full Text] [Related]
5. Effect of pituitary adenylate cyclase-activating polypeptide-27 on cerebral hemodynamics in healthy volunteers: A 3T MRI study. Ghanizada H; Al-Karagholi MA; Arngrim N; Ghanizada M; Larsson HBW; Amin FM; Ashina M Peptides; 2019 Nov; 121():170134. PubMed ID: 31449829 [TBL] [Abstract][Full Text] [Related]
6. The effect of pituitary adenylate cyclase-activating peptide-38 and vasoactive intestinal peptide in cluster headache. Vollesen ALH; Snoer A; Chaudhry B; Petersen AS; Hagedorn A; Hoffmann J; Jensen RH; Ashina M Cephalalgia; 2020 Nov; 40(13):1474-1488. PubMed ID: 32962406 [TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Hansen JM; Sitarz J; Birk S; Rahmann AM; Oturai PS; Fahrenkrug J; Olesen J; Ashina M Cephalalgia; 2006 Aug; 26(8):992-1003. PubMed ID: 16886936 [TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Rahmann A; Wienecke T; Hansen JM; Fahrenkrug J; Olesen J; Ashina M Cephalalgia; 2008 Mar; 28(3):226-36. PubMed ID: 18254893 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38. Amin FM; Hougaard A; Schytz HW; Asghar MS; Lundholm E; Parvaiz AI; de Koning PJ; Andersen MR; Larsson HB; Fahrenkrug J; Olesen J; Ashina M Brain; 2014 Mar; 137(Pt 3):779-94. PubMed ID: 24501094 [TBL] [Abstract][Full Text] [Related]
10. Effect of K Kokoti L; Al-Karagholi MA; Elbahi FA; Coskun H; Ghanizada H; Amin FM; Ashina M Cephalalgia; 2022 Aug; 42(9):846-858. PubMed ID: 35301859 [TBL] [Abstract][Full Text] [Related]
11. Investigation of carbachol and PACAP38 in a human model of migraine. Schytz HW Dan Med Bull; 2010 Dec; 57(12):B4223. PubMed ID: 21122466 [TBL] [Abstract][Full Text] [Related]
12. Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache. Ghanizada H; Al-Karagholi MA; Arngrim N; Mørch-Rasmussen M; Metcalf-Clausen M; Larsson HBW; Amin FM; Ashina M J Headache Pain; 2020 Feb; 21(1):19. PubMed ID: 32093617 [TBL] [Abstract][Full Text] [Related]
13. PACAP-38 infusion causes sustained vasodilation of the middle meningeal artery in the rat: possible involvement of mast cells. Bhatt DK; Gupta S; Olesen J; Jansen-Olesen I Cephalalgia; 2014 Oct; 34(11):877-86. PubMed ID: 24563332 [TBL] [Abstract][Full Text] [Related]
14. Effect of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide on pancreatic, hepatic and duodenal mucosal bicarbonate secretion in the pig. Glad H; Ainsworth MA; Svendsen P; Fahrenkrug J; Schaffalitzky de Muckadell OB Digestion; 2003; 67(1-2):56-66. PubMed ID: 12743442 [TBL] [Abstract][Full Text] [Related]